Theramyt Novobiologics

About:

Theramyt develops therapies for disease areas such as oncology, rheumatoid arthritis, diabetes, and metabolic disorders.

Website: http://theramyt.com

Top Investors: Accel, Chiratae Ventures, Karnataka Information Technology Venture Capital Fund, Aarin Capital

Description:

Theramyt is a unique bio-enterprise building tomorrow’s biologics – biobetters. We apply our drug designing and platform technology strengths to deliver novel therapies for disease areas such as oncology, rheumatoid arthritis, diabetes and metabolic disorders.

Total Funding Amount:

$4.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bengaluru, Karnataka, India

Founded Date:

2013-01-01

Contact Email:

info(AT)theramyt.com

Founders:

Kavitha Iyer Rodrigues, Sohang Chatterjee

Number of Employees:

11-50

Last Funding Date:

2013-10-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai